Cavernous malformations can be an incidental finding or can present with focal neurologic deficits, seizures, or headache, with or without associated hemorrhage. Management of the CM lesion requires knowledge of the natural history of the disease compared with the risk of surgical intervention. Surgery is often considered for symptomatic patients with lesions in a noneloquent location. Medical management is warranted for symptoms related to the CM.
Review Mayo Clin Proc 2020 Sep;95(9):2005-2020. doi: 10.1016/j.mayocp.2019.11.005. Epub 2020 Jun 27.
Cerebral Cavernous Malformation: What a Practicing Clinician Should Know
Kelly D Flemming 1, Giuseppe Lanzino 2Affiliations expand
- PMID: 32605781
- DOI: 10.1016/j.mayocp.2019.11.005
Abstract
Cavernous malformations (CMs) are angiographically occult, low-flow vascular malformations of the central nervous system. They are acquired lesions, with approximately 80% of patients having the sporadic form and 20% the familial form of the disease. The lesions may also develop years after radiotherapy. At the microscopic level, they consist of endothelium-lined cavities (or “caverns”) containing blood of different ages. The endothelium proliferates abnormally, and tight junctions are absent or dysfunctional, resulting in leakiness of the endothelium and clinical manifestations in some patients. Cavernous malformations can be an incidental finding or can present with focal neurologic deficits, seizures, or headache, with or without associated hemorrhage. Management of the CM lesion requires knowledge of the natural history of the disease compared with the risk of surgical intervention. Surgery is often considered for symptomatic patients with lesions in a noneloquent location. Medical management is warranted for symptoms related to the CM. Research aimed at understanding the genes and signaling pathways related to CMs have provided potential drug targets, and clinical trials are underway to determine whether medications reduce the risk of future bleeding without surgery or modify the disease course. In addition, recent epidemiologic data have aided practitioners in determining how to treat comorbid conditions in patients with a potentially hemorrhagic lesion. This review provides an overview of the epidemiology, presentation, and clinical management of CMs.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Similar articles
- Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.Idiculla PS, Gurala D, Philipose J, Rajdev K, Patibandla P.Eur Neurol. 2020;83(4):360-368. doi: 10.1159/000508748. Epub 2020 Jul 30.PMID: 32731220 Review.
- Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations.Flemming KD, Kumar S, Brown RD Jr, Lanzino G.World Neurosurg. 2020 Jan;133:e767-e773. doi: 10.1016/j.wneu.2019.09.161. Epub 2019 Oct 9.PMID: 31605843
- Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level.Flemming KD, Kumar S, Brown RD Jr, Singh RJ, Whitehead K, McCreath L, Lanzino G.Cerebrovasc Dis. 2020;49(2):216-222. doi: 10.1159/000507789. Epub 2020 Apr 29.PMID: 32348981
- Intracranial cavernous malformations.Rivera PP, Willinsky RA, Porter PJ.Neuroimaging Clin N Am. 2003 Feb;13(1):27-40. doi: 10.1016/s1052-5149(02)00060-6.PMID: 12802939 Review.
- Natural history of cerebral cavernous malformations.Ene C, Kaul A, Kim L.Handb Clin Neurol. 2017;143:227-232. doi: 10.1016/B978-0-444-63640-9.00021-7.PMID: 28552144 Review.
Cited by 3 articles
- Inactivation of Cerebral Cavernous Malformation Genes Results in Accumulation of von Willebrand Factor and Redistribution of Weibel-Palade Bodies in Endothelial Cells.Much CD, Sendtner BS, Schwefel K, Freund E, Bekeschus S, Otto O, Pagenstecher A, Felbor U, Rath M, Spiegler S.Front Mol Biosci. 2021 Jul 9;8:622547. doi: 10.3389/fmolb.2021.622547. eCollection 2021.PMID: 34307446 Free PMC article.
- Identification of a Novel CCM1 Frameshift Mutation in a Chinese Han Family With Multiple Cerebral Cavernous Malformations.Zhang F, Xue Y, Zhang F, Wei X, Zhou Z, Ma Z, Wang X, Shen H, Li Y, Cui X, Liu L.Front Neurosci. 2020 Sep 23;14:525986. doi: 10.3389/fnins.2020.525986. eCollection 2020.PMID: 33071727 Free PMC article.
- Intracranial and extracranial vascular manifestations of patients with a clinical diagnosis of Klippel-Trenaunay syndrome.Covington TN, Anderson KR, Tollefson MM, Guerin JB, Brinjikji W.Neuroradiology. 2021 Mar;63(3):409-415. doi: 10.1007/s00234-020-02560-3. Epub 2020 Oct 16.PMID: 33064164
